Project Grant HT94252410857
Award Date
8/15/24
Completion Date
8/14/26
Dollars Obligated
$319K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
New York, NY 10029, USA
Similar Awards
The Defense Health Agency awarded a $2,475,390.00 Project Grant to the Icahn School of Medicine at Mount Sinai (ISMMS) under the Military Medical Research and Development program (CFDA 12.420). The grant, with a performance period from September 1, 2024 to August 31, 2028, will fund a multifaceted intervention titled "MULTIFACETED INTERVENTION TO RESTORE RESILIENCE AND OVERCOME RISK (MIRROR)." As a renowned academic medical center, ISMMS will leverage its expertise in areas such as...
This $949,181 federal Project Grant award was provided by the U.S. Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program. The grant will fund research by the Icahn School of Medicine at Mount Sinai to investigate the association between cortical lesions and physical/cognitive disability in multiple sclerosis using novel, clinically feasible MRI methods. The research aims to advance the understanding and treatment of multiple sclerosis, a...
The Icahn School of Medicine at Mount Sinai (ISMMS) was awarded a $676,000 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "EPIGENETIC STUDIES OF CANDIDATE CELLS OF ORIGIN FOR DIFFUSE MIDLINE GLIOMA," is for a research project spanning from September 1, 2024, to August 31, 2026. The funding will support ISMMS's investigation into epigenetic factors that contribute to the development of diffuse...
The Defense Health Agency has awarded a $766,079 Project Grant to the Icahn School of Medicine at Mount Sinai to conduct research under the Military Medical Research and Development program (CFDA 12.420). The grant, which runs from September 1, 2023 to August 31, 2026, aims to "UNRAVEL THE EVOLUTION OF MELANOMA WITHIN THE HOST IMMUNE ECOSYSTEM." As a leading private medical research institution, the Icahn School of Medicine at Mount Sinai has a history of providing a wide range of...
The Department of the Army Medical Command awarded a $999,975.63 Project Grant titled "MOLECULAR MECHANISMS OF APOE4 VULNERABILITY TO ALZHEIMER'S DISEASE AND IDENTIFICATION OF NOVEL THERAPEUTIC TARGETS" to the Icahn School of Medicine at Mount Sinai (ISMMS) on April 1, 2025. This grant, funded under the Military Medical Research and Development (CFDA 12.420) program, supports advanced biomedical research initiatives focused on transforming healthcare for military service members and...
This $507,000 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) is supporting research at the Icahn School of Medicine at Mount Sinai (ISMMS) to study the role of exosomes in promoting prostate cancer metastasis and resistance to androgen deprivation therapy. The 2-year grant, awarded on June 15, 2024, will enable ISMMS to conduct innovative biomedical research with the goal of advancing understanding and treatment of...
The Icahn School of Medicine at Mount Sinai will receive $1,521,002 under a three-year Project Grant award from the Defense Health Agency. The grant will support research from August 1, 2023 to July 31, 2026 under the Military Medical Research and Development program (CFDA 12.420). Specifically, the funding will enable research to determine the contribution of lineage intermediate tumor cells during progression to T-SCNC. This work aligns with the Military Medical Research and Development...
The Icahn School of Medicine at Mount Sinai will receive $760,500 from the Defense Health Agency under a three-year Project Grant award through the Military Medical Research and Development program (CFDA 12.420). The grant will fund research to functionally identify high-dimensional driver combinations in basal-like breast cancer. Through February 1, 2023 to January 31, 2026, this award will support the Icahn School of Medicine's efforts to transform health care for service members and the...
The Icahn School of Medicine at Mount Sinai (ISMMS) was awarded a $437,420 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) federal grant program. The funding will support advanced biomedical research to leverage personalized stem cell therapy to overcome airway reconstruction challenges. The research initiative aims to transform healthcare for military service members and the broader public by exploring innovative...
The Defense Health Agency awarded a $1.687 million Project Grant to the Icahn School of Medicine at Mount Sinai under the Military Medical Research and Development federal grant program (CFDA 12.420) for the period of May 1, 2023 to April 30, 2027. The grant will fund research investigating the role of medial amygdala circuits in mediating the effects of diet on post-traumatic behavioral and metabolic complications. Through basic, applied, and advanced biomedical research, this project aims to...